Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02156258
Other study ID # FMSU2013-004A
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 2014
Est. completion date January 2017

Study information

Verified date May 2020
Source Fujifilm Medical Systems USA, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a case collection study of breast images using standard and new mammography technology.


Description:

This image acquisition study is designed to acquire the study image data and establish and document the clinical findings for each subject. This study will create a library of image data that will be used for future projects.


Recruitment information / eligibility

Status Completed
Enrollment 1232
Est. completion date January 2017
Est. primary completion date January 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

For Screening Subjects

- Be at least 40 years of age, are

- Asymptomatic,

- Scheduled for a routine screening mammogram

For Recall Subjects

- Be at least 18 years of age,

- Received a BIRADS 0 within the last 60 days

- Are recalled for additional imaging

For Diagnostic Subjects

- Be at least 18 years of age,

- Scheduled for a biopsy due to an assessment of Breast Imaging and Reporting Data (BI-RADS®) 4 or 5 after diagnostic work-up of a suspicious screening or clinical finding within the last 60 days.

- Understand requirements and willing to participate in study

Exclusion Criteria:

- Presence of a breast implant.

- Women with only a single breast; for example, post mastectomy patients.

- Is pregnant or believes she may be pregnant.

- A woman who has delivered and who has expressed the intention to breast-feed or is currently breast-feeding.

- A woman who has significant existing breast trauma within the last one year.

- Have self-reported severe non-focal or bilateral breast pain affecting subject's ability to tolerate digital mammography and/or breast tomosynthesis examinations.

- A woman who has had a mammogram performed for the purpose of therapy portal planning within the last year.

- Cannot, for any known reason, undergo follow-up digital mammography and/or breast tomosynthesis examinations (where clinically indicated) at the participating institution.

- Is an inmate (see US Code of Federal Regulations 45CFR46.306).

Study Design


Related Conditions & MeSH terms


Intervention

Device:
FFDM Mammography
Standard mammography image collection
DBT Mammography
Collection of breast images using DBT mammography

Locations

Country Name City State
United States University of North Carolina - at Chapel Hill Chapel Hill North Carolina
United States University of Iowa Hospitals & Clinics Iowa City Iowa
United States Elizabeth Wende Breast Care, LLC Rochester New York
United States University of Texas Health Science Center at San Antonio San Antonio Texas
United States Scottsdale Medical Imaging, Ltd Scottsdale Arizona

Sponsors (1)

Lead Sponsor Collaborator
Fujifilm Medical Systems USA, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants for Whom Study Image Data Were Collected This study created a library of image data to be used in future projects, future product development and regulatory submissions. There was no analysis conducted aside from confirmation of complete images and collected data , as this was merely a collection of images to be used in future reader studies. Sites were provided a target distribution of diagnostic, recall and screening cases to obtain. 20 Months
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2